Skip to content
Catalyst

PapersPMID:18680121

The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats.

Phytotherapy research2009The record ↗

  1. Finding, insufficient evidenceraisesHDL cholesterol

What moved

1 findingHow to read these marks →
  • “In diabetic rats, treatment with 4-hydroxyisoleucine did not affect glucose or liver damage markers, but did improve HDL-cholesterol levels (31% increase, p < 0.05).”
    Study
    animal · not in humans
    Population
    streptozotocin-induced diabetic rats (described as a type 2 diabetes model)

Study record

Design
animal study, in vivo
Species
animal
Population
Fructose-fed rats and streptozotocin-induced type 2 diabetic rats (two rat models of insulin resistance), plus control rats; fenugreek 4-hydroxyisoleucine
Participants
not reported
Comparator
not stated in the paper
Duration
56 days
Endpoints measured
12